Navigation Links
Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others
Date:2/6/2012

tor BioLogix 154910.128 Regeneron 155310.129 Rexahn 156110.130 Rigel 156510.131 Sanofi 156910.132 Santaris Pharma 157610.133 Scancell 158210.134 SciClone Pharmaceuticals 158610.135 Semafore Pharmaceuticals 159010.136 Shionogi 159610.137 Simcere Pharmaceuticals 160010.138 Spear Therapeutics 160810.139 SRI International 161210.140 Stainwei Biotech 161810.141 SuperGen 162210.142 Switch Pharma 162610.143 SynDevRx 163010.144 Taiho 163410.145 Tau Therapeutics 163810.146 ThromboGenics 164210.147 Tigris Pharmaceuticals 164610.148 ToolGen 165010.149 TopoTarget 165710.150 Tracon Pharmaceuticals 166110.151 UCB 166510.152 VBL Therapeutics 167210.153 Wilex 167610.154 Xerion 168211 Disclaimer 168612 Drug Index 168713 Company Index 1697

4.1 List of Figures

Figure 1: Visualization of Target-Target Interactions among Targets of Angiogenesis Affecting Drugs in Oncology 367Figure 2: The Drug-Target Competitive Landscape of Angiogenesis Affecting Drugs in Oncology - Large Cluster 369Figure 3: The Drug-Target Competitive Landscape Angiogenesis Affecting Drugs in Oncology - Smaller Clusters 370Figure 4: Head-to-Head Targeting Competitive Landscape of Angiogenesis Affecting Drugs in Oncology 371Figure 5: Distribution of Compound Strategies among Angiogenesis Affecting Cancer Drugs 703Figure 6: Primary Sub-cellular Localization of Drug Targets 704Figure 7: Number of Companies per Ranking Level 855

4.2 List of Tables

Table 1: Cancer Highlights'™ Five Pillar Drug Assessment 7Table 2: Breakdown of the Included Angiogenesis Affecting Drug Pipeline in Oncology by Stage of Development 37Table 3: Head to Head Target Competition among Angiogenesis Affecting Drugs in Oncology 37Table 4: Overview of Drug Target Strategy Themes 42Table 5: Terminally Ceased Targets of Angiogenesis Affecting Drugs in Oncology 43Table 6: Official Gene Name to Target Profle 44Table 7: Targets of Angiogenesis Affecting Drugs in Oncology Present in the Catalogue of Somatic
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
2. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
3. KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies
4. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
5. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
6. Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors
7. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
8. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
9. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... MOUNTAIN VIEW, Calif. , July 22, 2014 ... magnetic resonance imaging (MRI) market, Frost & Sullivan ... Award for Product Leadership. Siemens Healthcare,s FREEZEit solution, ... addresses the need for robust and motion-insensitive imaging. ... has boosted the evolution of body MRI imaging ...
(Date:7/22/2014)... England , July 22, 2014 Elekta ... announced today that The Christie NHS Foundation Trust ( ... will join a consortium whose mission is to develop ... (MRI) guided radiation therapy system. Such a system would, ... visualization of cancer targets. "The Christie ...
(Date:7/22/2014)... Ariz. , July 22, 2014  A ... of a SynCardia temporary Total Artificial ... Rochester,s Strong Memorial Hospital with the Freedom® portable ... Fontana, a 64-year-old retiree from a ... decades. He managed the condition with medications, an ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... FORD, Pa., March 29, 2012 Endo (Nasdaq: ENDP ... Bihl, will step down as head of the Endo devices operating ... successor, a comprehensive executive search has been initiated. Mr. ... acquisition of AMS and was named President and Chief Executive Officer ...
... VIEW, Calif., March 29, 2012  Based on its ... market, Frost & Sullivan recognizes Sensear with the ... Product Differentiation Excellence for its "high-noise communication" devices, ... products protect hearing while still enabling the user ...
Cached Medicine Technology:Endo Announces Departure of American Medical Systems President 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
(Date:7/22/2014)... CyraCom has been ranked as North America’s 6th largest ... industry. Released June 2014 by the market research firm ... Market: 2014," also ranked CyraCom as the 18th ... from 2013. , In 2013, Common Sense Advisory also ... – a subset of the language service industry. CyraCom ...
(Date:7/22/2014)... New York (PRWEB) July 22, 2014 ... new market report based on Molecular Diagnostics Market – ... to 2019 in addition to their comprehensive database. This ... market for clinical applications. It is valued at USD ... a CAGR of 11.1% from 2013 to 2019. Molecular ...
(Date:7/22/2014)... 22, 2014 University of the ... opened the doors of its state-of-the-art, $151 million campus ... heart of downtown San Francisco's South of Market (SoMa) ... a year. Those patients will now be greeted by ... iKiosks . , Advanced Kiosks engineering team designed ...
(Date:7/22/2014)... Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer ... for one of the most complex and difficult-to-treat ... , Locally advanced pancreatic cancer has the ... a cumulative five-year survival rate of only 4 ... rarely an option for patients because tumors often ...
(Date:7/22/2014)... SkillSurvey Inc., the leading provider ... make better hiring decisions, will be delivering a ... engagement and retention of contingent workers at the ... Conference being held in Orlando, Florida on July ... study featuring Metro Health, a hospital in Grand ...
Breaking Medicine News(10 mins):Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:SkillSurvey to Present Research on Contingent Workers at National Association for Health Care Recruitment IMAGE 2014 Conference 2
... can determine the gentleness of a surgeon while performing a ... and colleague//. ,The invention of Dr Vijay Maker, ... and Dr Joseph Talarico, a surgical resident at the same ... development. While the original idea is Maker's, Talarico designed the ...
... is time for impatient patients to travel abroad rather than ... ailments. Recently, a woman won the right to claim compensation ... In yet another case, a 63-year-old British woman who traveled ... confirmed absence of any genetic disorder. ,A recent ...
... in Japan has found migraine medication sumatriptan, known by ... for pain// due to trigeminal neuralgia up to eight ... migraine medication could provide relief for people who suffer ... found it produced rapid and significant pain relief without ...
... Tamil Nadu Hindu Religious and Charitable Endowment Minister P T ... a train and died at a private hospital at Dindigul ... from the Madurai Central Constituency, was also the speaker of ... survived by his wife Rukmani and a son, who is ...
... is found that there is an increase in number of ... action// to tackle young criminals. According to the statistics the ... criminal offences due to alcohol increased by more than 150 ... crimes and theft. But the figures of the number of ...
... Indiana University Bloomington have reported that mouse sperm cells ... cells were bang on target, even when ovary extracts ... exhibit chemotaxis toward extracts from various female reproductive organs, ... known," said IUB Associate Professor of Chemistry Stephen C. ...
Cached Medicine News:Health News:Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain 2Health News:Sperm Cells attracted By Ovary Scent, Even in Weakened State 2
... In certain hernia and soft tissue ... fascial defects, it is sometimes necessary ... one surface, while minimizing tissue attachment ... a soft, conformable, ePTFE sheet material ...
... Bard Dulex mesh is a dual-sided ePTFE ... side is a micro-porous structure designed to minimize ... side is a macro-porous structure designed to promote ... size of approximately 800 microns, which is nearly ...
... mesh is the first polypropylene mesh ... Visilex mesh directly addresses the critical ... specifically, it delivers maximum visibility, enhanced ... after insertion through the trocar.,Visilex mesh ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: